ADARB2 (Adenosine Deaminase Rna Specific B2), also known as ADAR3, known to antagonize ADAR1 and ADAR2 by competing with them36,37 also showed some decrease in high-grade gliomas. Here, ADARB2 is linked to central nervous system cancer.